Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 study update reporting efficacy and safety results of bimekizumab in adult Korean participants with moderate to severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate to Severe Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2024-03-22